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The classic definition of hypercalciuria, an upper normal
limit of 200mg/day, is based on a constant diet restricted in
calcium, sodium, and animal protein; however, random diet
data challenge this. Here our retrospective study determined
the validity of the classic definition of hypercalciuria by
comparing data from 39 publications analyzing urinary
calcium excretion on a constant restricted diet and testing
whether hypercalciuria could be defined when extraneous
dietary influences were controlled. These papers
encompassed 300 non-stone-forming patients, 208 patients
with absorptive hypercalciuria type I (presumed due to
high intestinal calcium absorption), and 234 stone formers
without absorptive hypercalciuria; all evaluated on a constant
restricted diet. In non-stone formers, the mean urinary
calcium was well below 200mg/day, and the mean for
all patients was 127±46mg/day with an upper limit of
219mg/day. In absorptive hypercalciuria type I, the mean
urinary calcium significantly exceeded 200mg/day in all studies
with a combined mean of 259±55mg/day. Receiver operating
characteristic curve analysis showed the optimal cutoff point
for urinary calcium excretion was 172mg/day on a restricted
diet, a value that approximates the traditional limit of
200mg/day. Thus, on a restricted diet, a clear demarcation
was seen between urinary calcium excretion of kidney stone
formers with absorptive hypercalciuria type I and normal
individuals. When dietary variables are controlled, the classic
definition of hypercalciuria of nephrolithiasis appears valid.
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Flocks1 first found the association of hypercalciuria with
nephrolithiasis in 1939. In 1958, Albright et al.2 and
Henneman et al.3 used the term ‘idiopathic hypercalciuria’
to describe hypercalciuria of unknown origin among patients
with calcareous renal stones. Idiopathic hypercalciuria was
initially deemed metabolic in origin owing to intestinal
hyperabsorption of calcium.4,5 Thus, the term ‘absorptive
hypercalciuria’ was coined.4,5 Supporting evidence for
absorptive hypercalciuria was derived from metabolic studies
showing low fecal calcium content and restored urinary
calcium excretion following treatment with a known dietary
calcium binder, sodium cellulose phosphate.6,7 Since the
original classification of absorptive hypercalciuria,5 extensive
research has explored the underlying pathophysiologic
mechanism(s) of a more severe variant termed absorptive
hypercalciuria type I (AH-I).8 The characteristic features of
AH-I are normocalcemia, hypercalciuria, intestinal hyper-
absorption of calcium, and normal or suppressed values of
serum parathyroid hormone and urinary cyclic adenosine
30,50 monophosphate. In contrast, patients designated as the
absorptive hypercalciuria Type II (AH-II) subtype share most
characteristics with AH-I, but their urinary calcium may fall
below 200mg/day when placed on a restricted diet.
An epidemiologic study has suggested the lack of a clear
demarcation between urinary calcium excretion of kidney
stone formers and normal subjects on an ad-lib diet.9 This
finding may misconstrue that hypercalciuria is not a distinct
metabolic entity, but simply just an upper end of normal.
Most misunderstandings in the distinction of ‘normal’ versus
‘abnormal’ urinary calcium levels results from the lack of
consideration of dietary influences on urinary calcium
excretion.10–17 Therefore, it is important to establish the
metabolic origin of hypercalciuria, specifically in AH-I,
through dietary control.8 The ‘classic definition’ of hypercal-
ciuria (normal upper limit of 200mg/day) was determined
following the application of a constant metabolic diet
restricted in calcium, phosphorus, and sodium.5
The aim of this retrospective data analysis is to ascertain
the validity of the classic definition of hypercalciuria by
comparing data from 39 previous publications analyzing
urinary calcium excretion on a constant restricted diet to test
the hypothesis that hypercalciuria can be distinctly defined
when extraneous dietary influences are controlled.
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RESULTS
24-H urinary calcium in non-stone-forming subjects
Among individual reports, the mean 24-h urinary calcium
for non-stone-forming subjects ranged from 100 to
169mg/day (Figure 1). For all 300 subjects, the combined
mean urinary calcium was at 127±46 s.d. mg/day, ranging
(defined as ±2 s.d. of the mean) from 35 to 219mg/day
(Figure 1). The mean values for urinary calcium from
individual studies plotted against percentage of men in
respective reports are depicted in Figure 2. There was a
positive association between gender and urinary calcium
excretion (r¼ 0.55, Po0.0001). Moreover, the mean 24-h
urinary calcium rose modestly with increased calcium intake,
reaching a plateau at about 200mg/day (Figure 3).
24-H urinary calcium in AH-I stone formers
The mean value for urinary calcium exceeded 200mg/day in
every study, and exceeded the upper normal limit for non-
stone-forming subjects in all but one study (Figure 4).
Combining all 208 subjects, the mean±s.d. urinary calcium
was 259±55mg/day (range 149 to 369), which was
significantly higher than that of non-stone-forming subjects
(Po0.0001). Furthermore, the mean urinary calcium rose
significantly with a modest increase in calcium intake, and
remained elevated with higher calcium intakes. Non-stone-
forming subjects and patients with AH-I were separated by
a value of 220mg/day, with a 95% confidence interval (CI)
of non-stone formers contained entirely below, and AH-I
contained entirely above this value (Figure 3).
24-H urinary calcium in stone formers without AH-I
For all 234 stone-forming patients without AH-I, the
mean urinary calcium of 196±51 (with a range of 94 to
298mg/day) was significantly higher than that of non-stone-
forming subjects, but significantly lower than that of patients
with AH-I (Po0.0001). However, the mean urinary
calcium was variable, exceeding the upper limits of normal,
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Figure 1 | From 24 studies involving 300 non-stone-forming
subjects conducted on a constant restricted diet, 24-h urinary
calcium is displayed according to the year of publication.
For each study, mean±s.d. is depicted as vertical bars. For all
300 subjects, mean±2 s.d. are shown as long and short dashed
horizontal lines. In this report, urinary calcium was expressed as
mg/day, because of the perception that this expression would be
familiar to the readership of this journal. Urinary calcium in
mg/day divided by 40 equals the amount in mmol/day.
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Figure 2 |Urinary calcium on constant restricted diet from
24 reports of non-stone-forming subjects plotted against the
corresponding percentage of men. Vertical bars indicate the
mean±s.d. of individual studies.
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Figure 3 |Dependence of urinary calcium when calcium intake
alone is increased and other components are kept the same.
Vertical bars depict mean±s.d. of individual studies for patients
with absorptive hypercalciuria type I (AH-I) and non-stone-
forming subjects.
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Figure 4 | 24-H urinary calcium (mean±s.d.) in AH-I and stone
formers without AH-I during a constant restricted diet. Vertical
bars depict mean±s.d. of individual studies according to the year
of publication. The dashed horizontal lines represent the mean
value of combined subjects in each group. The shaded area
encloses the meanþ 2 s.d. of non-stone-forming subjects from
Figure 1. AH-I, absorptive hypercalciuria type I.
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non-stone-forming subjects in five reports, nearing the upper
limits in 16 reports, and approaching the mean in two reports
(Figure 4).
Receiver operating characteristic analysis between stone
formers (with and without AH-I) and non-stone formers
The receiver operating characteristic (ROC) curve, generated
by logistic regression with the stone-forming group as the
dependent variable, showed urinary calcium on a restricted
diet to be a significant predictor of stone formation (ROC
area under the ROC curves¼ 0.87, 95% CI: 0.83–0.91).
At a 200mg/day cutpoint, the sensitivity was 0.68 (95% CI
0.61–0.75), specificity was 0.90 (95% CI 0.84–0.94), positive
predictive value was 0.90 (95% CI 0.85–0.94), and negative
predictive value was 0.68 (95% CI 0.61–0.74). On the
basis of Youden’s Index, a cutpoint of 172mg/day would
be the ‘optimal’ cutpoint with sensitivity of 0.82 (95% CI
0.77–0.87), specificity of 0.81 (95% CI 0.73–0.83), positive
predictive value of 0.85 (95% CI 0.79–0.90), and negative
predictive value of 0.78 (95% CI 0.70–0.84; Figure 5).
Meta-analysis of 24-h urinary calcium on a constant
restricted diet
A meta-analysis was performed in 20 previous studies
evaluating the 24-h urinary calcium values in paired groups
of subjects consisting of non-stone-forming subjects, stone
formers without AH-I, and patients with AH-I. The difference
in the mean urinary calcium between non-stone-forming
subjects and AH-I ranged from 100mg/day to 185mg/day
in individual studies (Figure 6). For the combined groups,
the difference of 142mg/day between the two groups (with a
lower limit of 152mg/day and upper limit of 132mg/day)
was also significant (Po0.0001). The mean urinary calcium in
non-stone-forming subjects differed from stone formers
without AH-I by 15mg/day to 130mg/day in individual
studies (Figure 6). For the combined groups, the difference of
38mg/day (44 to 32mg/day) was significant (Po0.0001).
DISCUSSION
The classic definition of hypercalciuria that uses a normal
upper limit of 200mg/day on a constant restricted diet18,19
was recently disputed.9 It is true that when evaluated on a
random diet, urinary calcium excretion of stone formers was
statistically higher than that of non-stone-forming subjects,
but overlapped extensively with the control group without
stones. This carries the connotation that hypercalciuria is not
metabolic in origin, but may represent a continuous variable
with stone formers occupying the upper part of the same
distribution curve as non-stone-forming subjects.
In this retrospective data review of 39 previously
published studies, we tested the hypothesis that patients
with AH-I can be differentiated from non-stone-forming
subjects on the basis of 24-h urinary calcium when evaluated
on a constant restricted diet. The mean urinary calcium
for non-stone-forming subjects was well below 200mg/day in
each separate study, and the mean for all studies combined
was 127mg/day. In addition, the upper limit of 217mg/day
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Figure 5 |Receiver operating characteristic (ROC)
curve analysis. AUC, area under the ROC curve; CI, confidence
interval.
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Figure 6 |Meta-analysis of 24-h urinary calcium between AH-I and non-stone-forming subjects (NSF; left panel), and between
stone formers without AH-I (other SF) and non-stone-forming subjects (right panel). For individual studies and combined studies
(combined effect), the difference in the mean urinary calcium between the two groups are plotted. The circles depict the mean
and horizontal lines enclosing circles represent lower and upper limits. AH-I, absorptive hypercalciuria type I.
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neared the classic definition of hypercalciuria.18,19 As noted,
ROC analysis revealed that the optimal cutpoint for urinary
calcium excretion was 172mg/day on a restricted diet
(Figure 5). This value approximates the traditionally
recommended limit of 200mg/day.
We also reviewed urinary calcium data from non-stone-
forming subjects and patients with AH-I, in whom calcium
intake alone was increased while keeping other components
constant. Urinary calcium was clearly separable, with higher
values in AH-I at all calcium intakes, indicative of enhanced
intestinal calcium absorption (Figure 3). These results do, in
fact, suggest that urinary calcium is metabolic in origin and
predominantly derived from intestinal hyperabsorption
of calcium. However, the concurrent contribution of other
target organs such as the kidney and/or bone cannot be
excluded.20
The above findings were supported by a metabolic study
comparing the effect of low calcium intake (400mg/day)
with high calcium intake (1 g/day) in 25 normal subjects and
36 subjects with absorptive hypercalciuria defined by
exaggerated calciuric response to oral calcium load.21 In
normal subjects, urinary calcium was 137±54mg/day with
low calcium intake and 178±59mg/day with high calcium
intake. In patients with absorptive hypercalciuria, urinary
calcium was 239±52mg/day with low calcium intake and
359±74mg/day with high calcium intake. These results
affirm our retrospective data analysis, not only on the
definition of hypercalciuria and segregation of urinary
calcium between AH-I and non-stone-forming subjects, but
also on the varying responses to high calcium intake.
The metabolic origin of AH-I is also supported by
extensive pathophysiologic studies. Differences in ‘intestinal
adaptation’ to changes in calcium intake segregates normal
subjects from those with AH-I. In normal subjects, the rise in
urinary calcium from increased calcium intake becomes
attenuated after a month of high calcium intake,22,23 believed
to be due to a reduction in intestinal calcium absorption
from suppression of parathyroid function and calcitriol
synthesis. This adaptation might partially explain the
diminishing rise in urinary calcium following high calcium
intake in normal subjects.5,21 However, this mechanism is
partially lost in AH-I subjects, suggesting a lack of intestinal
adaptation.22 The unique metabolic origin of AH-I is also
supported by extensive research elucidating the pathophy-
siology of this condition, including the selective involve-
ment of jejunum using intestinal perfusion24 and indepen-
dence of intestinal hyperabsorption from circulating
concentration of calcitriol25 and/or treatment with adreno-
corticosteroids,26 orthophosphate,27 or thiazides.28
In this study, the mean values for 24-h urinary calcium in
stone formers without AH-I was significantly higher than
that in non-stone-forming subjects, but less than that in
AH-I. One explanation of these results is the inclusion of
patients with AH-II, a less severe form of absorptive
hypercalciuria compared with AH-I, among the stone
formers without AH-I group. Second, in two studies, stone
formers were not separated according to different causes.29,30
Therefore, some included subjects may have had AH-I. Third,
nephrolithiasis is a heterogeneous entity.8,31 Thus, some
stone formers without AH-I might have had hypercalciuria
due to other disturbances.
It is important to note that selection of AH-I subtype was
unbiased as this classification was made following determina-
tion of intestinal hyperabsorption of calcium and normal
parathyroid hormone, and not by high baseline urinary
calcium excretion. Because of the limited published data on
AH-II, we are precluded from analyzing combined group of
AH-I and AH-II. We speculate that the combined group
might resemble stone formers without AH-I, with inter-
mediate values in 24-h urinary calcium and distribution
profile between AH-I and non-stone-forming subjects.
The results of this study do not refute the conclusions
made by two cross-sectional, epidemiologic studies showing
that the relative risk of stone formation increases, but not in a
linear manner, with increasing urinary calcium on an ad-lib
diet.9,32 It contrast, our study identifies a population of
kidney stone formers with a specific pathophysiologic
mechanism of abnormal calcium metabolism mainly due to
intestinal calcium hyperabsorption.5,33 On a random diet,
there was an indistinct demarcation in urinary calcium
between stone formers and non-stone-forming subjects.9
This less clear-cut delineation could have resulted from
dietary variations and inclusion of less-active stone formers.
Furthermore, urinary sodium and uric acid were high,
indicative of salt overuse and animal protein excess––factors
that are known to increase urinary calcium excretion.10–13
Second, stone formers evaluated on a random diet likely had
higher intestinal calcium absorption than control subjects, as
their urinary calcium represented a greater fraction of dietary
calcium.32
Studies conducted on a random diet are helpful in
revealing the effect of diet and lifestyle on urinary calcium
excretion in a routine setting. In particular, such studies have
emphasized how urinary calcium can be modified by the
intake of sodium,8,11 animal proteins,12,13 acid ash content,14
and magnesium.16 Without controlling these dietary influ-
ences, however, the detection of hypercalciuria due to an
underlying metabolic abnormality (for example, high cal-
cium absorption in AH-I) may be difficult.
There are certain limitations in our analysis, mostly due to
the retrospective nature inherent in such analyses. First,
non-stone-forming subjects and patients with AH-I were not
matched according to the number of studies, subjects, and
dates of evaluation. This deficiency was partly mitigated by
the extensive database comprising a large number of studies
conducted over a long duration. Second, in evaluating the
effect of varying calcium intakes, the number of patients and
reports in AH-I was sparse.
In conclusion, the classic definition of hypercalciuria
of nephrolithiasis with an upper normal limit of 200mg/day
is valid when dietary variables are controlled by a constant
restricted diet (Figure 5). The metabolic origin of hypercal-
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ciuria in AH-I is indicated by a clear separation in 24-h
urinary calcium excretion on the restricted diet from non-
stone-forming subjects, distinct distribution profile, and
exaggerated urinary calcium excretion when calcium intake
alone is increased.
MATERIALS AND METHODS
This is a retrospective analysis of previously published inves-
tigations comprising 208 kidney stone formers with AH-I,
234 stone formers without AH-I, and 300 non-stone-forming
subjects.5,11,12,18,19,22,25,26,28–30,33–53 Among them, 51% of non-stone-
forming subjects,5,18,19,25,26,29,30,33–35,37–40,45,47–49 79.3% of AH-I stone-
forming patients5,19,25,26,40,41,43,46 and 69.1% of stone-forming subjects
without AH-I5,19,25,28,29,36,37,40–42,45,48 were men. All subjects were
evaluated while on a constant restricted diet consisting of 400mg
calcium, 100 mEq sodium, 800mg phosphorus, and limited acid
ash content.
Patients with calcium excretion greater than 200mg/day on a
restricted diet, low fasting urinary calcium excretion, and normal or
low serum parathyroid hormone concentrations were categorized
as AH-I. Moreover, fractional calcium absorption from forearm
counting,35 fecal recovery of orally administered 47radiocalcium (ref. 5)
and/or calciuric response to an oral calcium load8 were used to
establish the diagnosis of AH-I. Those subjects with urinary calcium
less than 200mg/day on a restricted diet were classified as having
absorptive AH-II.8 The stone formers who do not fit the AH-I
category included patients classified as AH-II, hypocitraturic
calcium nephrolithiasis, gouty diathesis with calcium stones,
hyperuricosuric calcium urolithiasis, and normocalciuric nephro-
lithiasis. As idiopathic hypercalciuria was a term used before the
appellation AH-I was introduced,2 patients previously categorized
with idiopathic hypercalciuria were included in the AH-I group.18
Statistical analysis
Mean and standard deviation of data from multiple studies were
estimated by weighted averages of the individual study means and
standard deviations on the basis of sample size. Urinary calcium
typically has a skewed, lognormal distribution when measured on an
ad-lib diet. However, the distribution of urinary calcium in our
subjects while on a constant restricted calcium diet was not skewed
and was consistent with a normal distribution. Weighted Pearson’s
correlation analysis was used to assess the association between
prevalence of males and mean urinary calcium excretion.
Receiver operating characteristic curve analysis was performed
on individual data available on 154 calcium stone formers and 205
non-stone formers (with and without AH-I) on a 400mg calcium-
restricted diet. ROC curves were generated from the logistic
regression models with the stone-forming group as the dependent
variable. The area under the ROC curves was compared using a non-
parametric approach.54
For the meta-analysis, the data for number of subjects, mean and
standard deviation were extracted for each study. Comparisons
between stone formers and non-stone-forming subjects and related
effect sizes were made with a fixed-effect meta-analysis model.49 The
meta-analysis was conducted using Comprehensive Meta-Analysis
version 2.2 (Biostat, Englewood, NJ). Other analyses were conducted
with SAS version 9.2 (SAS Institute, Cary, NC).
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